8-K: OneMedNet Receives Nasdaq Deficiency Notice

OneMedNet Corporation has been notified by Nasdaq of non-compliance with the minimum $1.00 bid price requirement.

Summary

• OneMedNet Corporation received a formal notice from Nasdaq on April 14, 2026, regarding non-compliance with the $1.00 minimum bid price rule.
• The company failed to maintain a closing bid price of at least $1.00 for 30 consecutive business days.
• The company has been granted an initial 180-day grace period, expiring October 12, 2026, to regain compliance.
• To regain compliance, the stock must close at or above $1.00 for at least ten consecutive business days within the grace period.
• Management is considering options to regain compliance, including a potential reverse stock split.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development, as it highlights downward pressure on the stock price and introduces the risk of delisting.

Positives

• The company has a clear 180-day window to address the deficiency before facing immediate delisting risks.
• Management has publicly acknowledged the issue and is actively monitoring the situation.

Negatives

• The company is currently in violation of Nasdaq Listing Rule 5550(a)(2).
• The stock price has remained below the $1.00 threshold for at least 30 consecutive business days.
• There is no guarantee that the company will be able to regain compliance within the allotted timeframe.

Risks

• Potential delisting from The Nasdaq Capital Market if compliance is not regained by October 12, 2026.
• Potential need for a reverse stock split, which may negatively impact shareholder sentiment.
• Risk of reduced liquidity and institutional investment if the stock is moved to the OTC markets.

Future Outlook

The company intends to monitor its stock price and may implement measures, such as a reverse stock split, to regain compliance with Nasdaq listing standards.

Management Comments

• The Company intends to continue to actively monitor the bid price of its common stock and may, if appropriate, consider implementing available options to regain compliance with the Bid Price Rule, which options may include effecting a reverse stock split, if necessary.

Industry Context

StockSavvy.ai notes that receiving a deficiency notice for bid price is a common challenge for small-cap growth companies during periods of market volatility or lack of institutional momentum.

Comparison to Industry Standards

• The 180-day grace period is standard practice for Nasdaq-listed companies facing bid price deficiencies.
• Many small-cap healthcare technology firms utilize reverse stock splits as a last-resort mechanism to maintain exchange listing status.

Stakeholder Impact

• Shareholders face uncertainty regarding the potential for a reverse stock split.
• Institutional investors may be restricted from holding the stock if it is delisted from Nasdaq.

Next Steps

• Monitor the closing bid price of ONMD common stock.
• Evaluate the necessity of a reverse stock split.
• Work toward achieving a closing bid price of $1.00 or higher for ten consecutive business days.

Key Dates

Recommendation

A deficiency notice often signals underlying weakness in market valuation and potential future dilution or volatility associated with a reverse stock split, warranting a cautious or sell stance until compliance is secured.

Keywords

OneMedNet, ONMD, Nasdaq, delisting, bid price, compliance, reverse stock split